ASTRIA THERAPEUTICS INC (ATXS)

Tuesday's after hours session: top gainers and losers

What's going on in today's after hours session

Astria Therapeutics to Present at Upcoming European Academy of Dermatology and Venerology Congress

ATXS Makes Notable Cross Below Critical Moving Average

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Astria Therapeutics to Present at Upcoming Bradykinin Symposium

Astria Therapeutics to Participate in Upcoming Morgan Stanley 22nd Annual Global Healthcare Conference

ATXS Stock Earnings: Astria Therapeutics Misses EPS for Q2 2024

ATXS stock results show that Astria Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.

ATXS Stock Earnings: Astria Therapeutics Misses EPS for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Astria Therapeutics (NASDAQ:ATXS) just reported results for the second quarter ...

Astria Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

Astria Therapeutics Chooses Ypsomed’s YpsoMate as the Injection Device for STAR-0215 for the Treatment of Hereditary Angioedema

Astria Therapeutics to Participate in Upcoming 2024 Wedbush PacGrow Healthcare Conference

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ATXS Crosses Above Key Moving Average Level

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Astria Therapeutics to Present at Upcoming Jefferies Healthcare Conference

Astria Therapeutics to Present at Upcoming Eastern Allergy Conference

Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress

Commit To Buy Astria Therapeutics At $7.50, Earn 25.8% Annualized Using Options

ATXS Stock Earnings: Astria Therapeutics Misses EPS for Q1 2024

ATXS stock results show that Astria Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.

ATXS Stock Earnings: Astria Therapeutics Misses EPS for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Astria Therapeutics (NASDAQ:ATXS) just reported results for the first quarter o...

Astria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update

Astria Therapeutics to Present at Upcoming Society for Investigative Dermatology Annual Meeting

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ATXS Makes Notable Cross Below Critical Moving Average

Oversold Conditions For Astria Therapeutics (ATXS)

Astria Therapeutics Appoints Sunil Agarwal to Its Board of Directors

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Investors Land ATXS Even Lower Than Its Secondary Stock Offering

Notable Monday Option Activity: ATXS, UWMC, SMTC

Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAE

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ATXS Stock Earnings: Astria Therapeutics Misses EPS for Q4 2023

ATXS stock results show that Astria Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.

ATXS Stock Earnings: Astria Therapeutics Misses EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Astria Therapeutics (NASDAQ:ATXS) just reported results for the fourth quarter ...

Astria Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update

Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma & Immunology Annual Meeting

Commit To Purchase Astria Therapeutics At $10, Earn 31.8% Annualized Using Options

Astria Therapeutics to Present at Upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conference

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Noteworthy Tuesday Option Activity: ATGE, ATXS, KURA